Lack of suppression of glucagon during OGTT contributes to the reduced incretin effect in type 2 diabetes

被引：0
|
作者：
Knop, F. K.
Vilsboll, T.
Madsbad, S.
Holst, J. J.
Krarup, T.
机构：
[1] Univ Copenhagen, Dept Intenal Med F, Copenhagen, Denmark
[2] Univ Copenhagen, Dept Med Physiol, Copenhagen, Denmark
[3] Univ Copenhagen, Dept Endocrinol, Copenhagen, Denmark
来源：
DIABETOLOGIA | 2006年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0663
引用
收藏
页码：403 / 403
页数：1
相关论文
共 50 条
  • [41] Incretin-based therapy for type 2 diabetes: A real class effect?
    Savarese, Gianluigi
    Lund, Lars H.
    Rosano, Giuseppe M. G.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 227 : 141 - 142
  • [42] The incretin effect in type 2 diabetes in a Sub-Saharan African population
    Signe Tellerup Nielsen
    Belinda Kweka
    George Praygod
    Suzanne Filteau
    Mette Frahm Olsen
    Henrik Friis
    Daniel Faurholt-Jepsen
    Rikke Krogh-Madsen
    [J]. Clinical Diabetes and Endocrinology, 10 (1)
  • [43] The incretin effect in Korean subjects with normal glucose tolerance or type 2 diabetes
    Oh, Tae Jung
    Kim, Min Young
    Shin, Ji Yon
    Lee, Jung Chan
    Kim, Sungwan
    Park, Kyong Soo
    Cho, Young Min
    [J]. CLINICAL ENDOCRINOLOGY, 2014, 80 (02) : 221 - 227
  • [44] Improved Glycemic Control Enhances the Incretin Effect in Patients With Type 2 Diabetes
    An, Zhibo
    Prigeon, Ronald L.
    D'Alessio, David A.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (12): : 4702 - 4708
  • [45] Improved Glycemic Control Enhances the Incretin Effect in Patients with Type 2 Diabetes
    An, Zhibo
    Ali, Sadia
    Rogge, Colleen
    Hailes, Fay
    Bailey, Cathy
    Wenstrup, Brenda
    Reedy, Brianne
    Salehi, Marzieh
    D'Alessio, David A.
    [J]. DIABETES, 2011, 60 : A484 - A484
  • [46] Study of evolution of type 2 diabetes timeline and type 2 diabetes clinical phenotypes using insulin response morphology during OGTT
    Shinde, S. N.
    Shinde, R. S.
    Joshi, A. S.
    [J]. DIABETOLOGIA, 2019, 62 : S243 - S244
  • [47] The incretin effect in obese adolescents with and without type 2 diabetes: impaired or intact?
    Aulinger, Benedikt A.
    Vahl, Torsten P.
    Prigeon, Ron L.
    D'Alessio, David A.
    Elder, Deborah A.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2016, 310 (09): : E774 - E781
  • [48] Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes
    Holst, Jens J.
    Knop, Filip K.
    Vilsboll, Tina
    Krarup, Thure
    Madsbad, Sten
    [J]. DIABETES CARE, 2011, 34 : S251 - S257
  • [49] The role of glucagon in gastrointestinal-mediated glucose-disposal and incretin effect in patients with type 2 diabetes and normal glucose tolerant individuals
    Nielsen-Hannerup, E.
    Haedersdal, S.
    Lund, A.
    Maagensen, H. E. G.
    Holst, J. J.
    Knop, F. K.
    Vilsboll, T.
    [J]. DIABETOLOGIA, 2017, 60 : S239 - S239
  • [50] Role of GLP-1 induced glucagon suppression in type 2 diabetes mellitus
    Hare, Kristine Juul
    [J]. DANISH MEDICAL BULLETIN, 2010, 57 (09)
12345